Sonoma Pharmaceuticals, Inc. is a global healthcare leader in the development and production of stabilized hypochlorous acid (HOCl) products. Its products are used for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
168
Frequently Asked Questions
What is Market Cap of Sonoma Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Sonoma Pharmaceuticals Inc. market cap is $6.9M.
What is the 52-week high for Sonoma Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sonoma Pharmaceuticals Inc. 52 week high is $6.92 as of September 17, 2025.
What is the 52-week low for Sonoma Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sonoma Pharmaceuticals Inc. 52 week low is $1.75 as of September 17, 2025.
What is Sonoma Pharmaceuticals Inc. stock price today?
Sonoma Pharmaceuticals Inc. stock price today is $4.13.
What was Sonoma Pharmaceuticals Inc. stock price yesterday?
Sonoma Pharmaceuticals Inc. stock price yesterday was $4.20.
What is the PE ratio of Sonoma Pharmaceuticals Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Sonoma Pharmaceuticals Inc.’s P/E ratio is -1.71.
What is the Price-to-Book ratio of Sonoma Pharmaceuticals Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Sonoma Pharmaceuticals Inc. P/B ratio is 1.7011.
What is the 50-day moving average of Sonoma Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Sonoma Pharmaceuticals Inc. 50-day moving average is $3.98.
How many employess does Sonoma Pharmaceuticals Inc. has?
